The Impact of Hypertriglyceridemia On Prostate Cancer Development in Men Over 60 Years
An interesting, but it makes sense type of study, was discussed about the relationship between high levels of triglycerides (TG) and the development of prostate cancer, including more aggresive prostate cancer. It of course follows [...]
Morbidity and Treatment Regret in Men with Advanced Prostate Cancer
The question of today’s post is do men with advanced prostate cancer develop treatment regrets concurrent to their development of morbidity issues ( i.e.- myocardial infarction, congestive heart failure, angina, diabetes, stroke, circulation problems, inflammatory [...]
The White House Declares September as National Prostate Cancer Awareness Month
The White House Office of the Press Secretary For Immediate Release September 01, 2011 Presidential Proclamation — National Prostate Cancer Awareness Month […]
New Data on Long-Term Use of Firmagon® (degarelix) For Men with Advanced Hormone Dependant Prostate Cancer
New data, published September 1 in the Journal of Urology, shows that Firmagon® (degarelix) which is a gonadotropin-releasing hormone therapy (GnRH) given to men with advanced prostate cancer may be superior to leuprolide when used [...]
Light A Blue Light Bulb for Prostate Cancer Awareness Month – September
Light a Blue Bulb for Prostate Cancer Awareness Month, September 2011. This year, let’s take prostate cancer awareness building into our own hands. Light a Blue Bulb every night (or, for a few nights) during [...]
Cabozantinib, Promising, Still Controversial For the Treatment of Bone Mets in Prostate Cancer
Cabozantinib (cabo), has many of us prostate cancer survivor, educators and researchers simply scratching their heads. In trials, Cabozantinib demonstrated what some people have characterized as mind boggling activity against bone metastases. In trials the [...]